Prognostic value of test(s) for O(6)‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

Lignende værker

• Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
  af: McAleenan, Alexandra, et al.
  Udgivet: (2021)
• Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma
  af: McAleenan, Alexandra, et al.
  Udgivet: (2019)
• “MGMT for pt mgmt”: Is Methylguanine-DNA Methyltransferase Testing Ready for Patient Management?
  af: Iafrate, A. John, et al.
  Udgivet: (2008)
• Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression
  af: Zhu, Zhongling, et al.
  Udgivet: (2016)
• Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O(6)-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
  af: Bush, Zachary M., et al.
  Udgivet: (2010)